E. Ellen Jones
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
Also affiliated: Cincinnati Children's Hospital Medical Center (2005–2006); Los Alamos National Laboratory (1949); Medical University of South Carolina (2012–2018); Eastern Virginia Medical School (2011); College of Charleston (2014); Hammersmith Hospital (1960–1963); Yale University (1997); National Institute of Diabetes and Digestive and Kidney Diseases (2016); Neuropsychiatric Research Institute (1956); MUSC Hollings Cancer Center (2015); Michigan Headache and Neurological Institute (1956); Infectious Disease Consultants (2011); Saint Louis Zoo (2013); Institute of Infection and Immunity (2018); Indiana University School of Medicine (2018); University of Cincinnati (2005); Sunesis (United States) (2017); Cardiff University (2018); Miami University (2003–2005)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
E. Ellen Jones' research centers on the application of mass spectrometry imaging, particularly Matrix-Assisted Laser Desorption-Ionization (MALDI) imaging mass spectrometry, as a tool for biological and toxicological investigations. Her work has explored the utility of this technique in various fields, including neurology, where it can aid in understanding disease mechanisms and identifying biomarkers.
Recent publications demonstrate her focus on applying MALDI imaging mass spectrometry to analyze complex biological samples. This includes investigating N-glycan profiles in post-COVID-19 lung tissues to understand viral and immune cell interactions, and identifying markers of toxicity from in utero opioid exposures in mouse models. These studies highlight her commitment to using advanced analytical techniques to address critical health and toxicological questions.
Jones leads a research group and has a scholarly profile marked by 54 publications and 2,297 citations, with an h-index of 23. She has collaborated with researchers such as Dustyn A. Barnette, David A. Thorn, Laura K. Schnackenberg, and Elysia A. Masters, all affiliated with the National Center for Toxicological Research.
Metrics
- h-index: 23
- Publications: 54
- Citations: 2,353
Selected Publications
-
The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses (2024)
-
Applying imaging mass spectrometry to define the N-glycan profiles of co-localized virus and immune cell infiltrates in post-COVID-19 infected lung autopsy tissues (2022)
-
MALDI imaging mass spectrometry: an emerging tool in neurology (2021)
Collaboration Network
Top Collaborators
- MALDI imaging mass spectrometry: an emerging tool in neurology
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- MALDI imaging mass spectrometry: an emerging tool in neurology
- MALDI imaging mass spectrometry: an emerging tool in neurology
- Applying imaging mass spectrometry to define the N-glycan profiles of co-localized virus and immune cell infiltrates in post-COVID-19 infected lung autopsy tissues
- Applying imaging mass spectrometry to define the N-glycan profiles of co-localized virus and immune cell infiltrates in post-COVID-19 infected lung autopsy tissues
- Applying imaging mass spectrometry to define the N-glycan profiles of co-localized virus and immune cell infiltrates in post-COVID-19 infected lung autopsy tissues
- Applying imaging mass spectrometry to define the N-glycan profiles of co-localized virus and immune cell infiltrates in post-COVID-19 infected lung autopsy tissues
- Applying imaging mass spectrometry to define the N-glycan profiles of co-localized virus and immune cell infiltrates in post-COVID-19 infected lung autopsy tissues
- Applying imaging mass spectrometry to define the N-glycan profiles of co-localized virus and immune cell infiltrates in post-COVID-19 infected lung autopsy tissues
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
- The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
Similar Researchers
Based on overlapping research topics